These findings highlight the broader implications of microdeletions in 17p11.2, where the clinical phenotype of SMS may extend beyond the core symptoms driven by RAI1 haploinsufficiency to include additional features stemming from the deletion of contiguous genes, like FLCN. This evidence concerns the gene FLCN and Smith-Magenis syndrome.